US EditionPublished • loading... • Updated
Should medical marijuana be less stringently regulated? A drug policy expert explains what’s at stake
Rescheduling marijuana to Schedule III would ease federal research restrictions and align laws with 40 states' medical programs, despite opposition from some lawmakers.
Summary by The Conversation
4 Articles
4 Articles
The Conversation+3 Reposted by 3 other sources
Should medical marijuana be less stringently regulated? A drug policy expert explains what’s at stake
Reclassifying marijuana to a Schedule III drug would put it in a category with prescription drugs like ketamine. LPETTET/iStock via Getty ImagesMedical marijuana could soon be reclassified into a medical category that includes prescription drugs like Tylenol with codeine, ketamine and anabolic steroids. That’s because in December 2025, President Donald Trump signed an executive order to reschedule marijuana to a less restricted category, continu…
Coverage Details
Total News Sources4
Leaning Left1Leaning Right0Center2Last UpdatedBias Distribution67% Center
Bias Distribution
- 67% of the sources are Center
67% Center
L 33%
C 67%
Factuality
To view factuality data please Upgrade to Premium
